Morito Hayashi
Toho University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Morito Hayashi.
Acta neurochirurgica | 2011
Satoshi Iwabuchi; Tetsuya Yokouchi; Morito Hayashi; Kenichiro Sato; Norihiko Saito; Y. Hirata; Junichi Harashina; Haruo Nakayama; Masaki Akahata; Keisuke Ito; Hitoshi Kimura; Kazuya Aoki
BACKGROUND we investigated the clinical efficacy of intra-arterial administration of fasudil hydrochloride for cerebral vasospasm. METHOD we reviewed 90 cases treated with intra-arterial administration of fasudil hydrochloride between August 1998 and April 2009 and investigated the clinical efficacy for cerebral vasospasm. FINDINGS angiographic improvement of vasospasm was noted in all procedures. Eight had ischemic lesion on CT at discharge in Group A, which included 39 patients who presented angiographic and symptomatic vasospasm. However, 4 (50%) of these eight were recovered with a condition of GR. No patients showed ischemic lesion on CT in Group B, which included 51 patients who presented angiographic vasospasm without symptoms. Two (3.3%) of 59 patients who presented angiographic vasospasm without symptoms at the initial follow-up angiography had ischemic lesion on CT at discharge. The 1-year follow-up showed 78.9% of GR. No patient showed any adverse effects resulting from intra-arterial administration of fasudil hydrochloride. CONCLUSION intra-arterial administration of fasudil hydrochloride was an effective and safe management technique for vasospasm.
Journal of Ophthalmology | 2016
Masashi Ishii; Morito Hayashi; Fumihiko Yagi; Kenichiro Sato; Goji Tomita; Satoshi Iwabuchi
When internal carotid artery stenosis is accompanied by ocular ischemic syndrome, intervention is recommended to prevent irreversible visual loss. In this study, we used laser speckle flowgraphy to measure the ocular microcirculation in the optic nerve head before and after carotid artery stenting (CAS) of 40 advanced internal carotid stenosis lesions from 37 patients. The aim was to investigate the relationship between ocular microcirculation and the direction of ophthalmic artery blood flow obtained by angiography. We found that there was a significant increase in blood flow after CAS (P = 0.003). Peak systolic velocity as an indicator of the rate of stenosis was also significantly higher in the group with retrograde/undetected flow of the ophthalmic artery than in the group with antegrade flow (P = 0.002). In all cases where retrograde flow of the ophthalmic artery was observed before stenting, the flow changed to antegrade after stenting. Through the use of laser speckle flowgraphy, this study found that CAS can improve ocular microcirculation. Furthermore, while patients displaying retrograde flow of the ophthalmic artery before stenting have a poor prognosis, CAS corrected the flow to antegrade, suggesting that visual loss can be prevented by improving the ocular microcirculation.
Neuropathology | 2009
Norihiko Saito; Tsutomu Hatori; Kazuya Aoki; Morito Hayashi; Yoko Hirata; Kenichiro Sato; Haruo Nakayama; Junichi Harashina; Nozomu Murata; Zean Zhang; Hiroko Nonaka; Kazutoshi Shibuya; Satoshi Iwabuchi
As methods of cancer diagnosis and treatment improve, interest in metastatic brain tumors continues to increase. In the present study, we attempted to characterize genetically the dynamic changes occurring during brain metastasis formation by DNA microarray, and attempted to compare these findings with histological observations. Lewis lung carcinoma cells were injected into C57BL/6Ncrj mice carotid arteries. The mice were sacrificed at days 1–9 after injection. We performed histological observation and genome‐wide expression profiling using a DNA microarray. In histological observation, tumor cells were observed in capillary vessels at day 1 after injection. At day 3, the tumor cells had begun to proliferate. At day 6, the metastatic foci showed “perivascular proliferations”. Next, we performed a pairwise comparison of gene expression microarray data from day 1 to day 9 after injection. The first major change occurred between Phase Two and Phase Three. When hierarchical clustering was performed between different samples using the 867 genes, they could be classified into identical clusters for days 1 and 2, identical clusters for day 3 to day 5, and identical clusters for day 6 to day 9. For time course analysis, we extracted 623 genes by the pairwise comparison. By using the quality threshold (QT) nonhierarchical clustering method, we identified 37 expression patterns. These patterns can be separated into eight clusters by using the k‐means method. The microarray results reported here strongly suggest that a large number of genes exhibit a spike pattern, which is tantamount to phase‐specific expression.
Acta neurochirurgica | 2015
Satoshi Iwabuchi; Morito Hayashi; Tetsuya Yokouchi; Kenichiro Sato; Haruo Nakayama; Junichi Harashina; Junya Iwama; Masashi Ishii; Yu Hiramoto; Nozomi Hirai; Y. Hirata; Norihiko Saito; Keisuke Ito; Hitoshi Kimura; Kazuya Aoki
PURPOSE We evaluated patients treated with prophylactic intra-arterial administration of fasudil hydrochloride (IAF) after subarachnoid haemorrhage (SAH). MATERIALS AND METHODS Between August 1998 and December 2012, 92 patients with aneurysmal SAH were treated with IAF for angiographic vasospasm without ischemic symptoms after their follow-up angiography. Patients comprised 50 women and 42 men, aged 24-83 (mean 56.6) years. IAF consisted of 15 mg of fasudil hydrochloride dissolved in 20 ml physiological saline and injected through a catheter during approximately 15 min, after diagnostic angiography. The clinical outcome was evaluated using the Glasgow Outcome Scale (GOS) at discharge and ischemic lesions resulting from vasospasm were assessed on computed tomography (CT) scan at discharge. RESULTS Forty-eight patients underwent surgical clipping and 44 patients underwent endovascular coiling. Angiographic improvement was observed in all patients (100 %). At discharge, 76 (83.0 %) of 92 patients showed good recovery on GOS. Nine patients developed progression of delayed ischemic neurological deficits (DIND) and three of these patients had ischemic lesions on CT scans. No patient had any significant changes in vital signs or any other adverse effects resulting from IAF. CONCLUSION IAF therapy was safe and effective for patients with vasospasm following SAH. Prophylactic IAF therapy may prevent symptomatic vasospasm.
Case Reports in Medicine | 2011
Arata Tomiyama; Kazuya Aoki; Haruo Nakayama; Hideaki Izukura; Hitoshi Kimura; Junichi Harashina; Keisuke Ito; Morito Hayashi; Norihiko Saito; Takatoshi Sakurai; Toshiaki Oharaseki; Hitoshi Terada; Satoshi Iwabuchi
A 14-year-old was girl admitted to our hospital with a subcutaneous mass of the occipital head. The mass had grown for 6 years, after she had sustained a head injury at the age of 6, and was located directly under a previous wound. Skull X-ray Photograph (xp), computed tomography (CT), and magnetic resonance imaging (MRI) showed a bony defect and cystic changes in the skull corresponding to a subcutaneous mass. Bone scintigraphy revealed partial accumulation. The patient underwent total removal of the skull mass, and the diagnosis from the pathological findings of the cyst wall was fibrous dysplasia (FD). The radiographic findings for cystic cranial FD can be various. Progressive skull disease has been reported to be associated with head trauma, but the relationship between cranial FD and head trauma has not been previously reported. Previous studies have suggested that c-fos gene expression is a key mechanism in injury-induced FD.
Cancer Research | 2017
Norihiko Saito; Kazuya Aoki; Nozomi Hirai; Satoshi Fujita; Junya Iwama; Masashi Ikota; Haruo Nakayama; Morito Hayashi; Keisuke Ito; Takatoshi Sakurai; Satoshi Iwabuchi
Glioblastoma, the most common adult glioma, is associated with a dismal prognosis. Treatment with bevacizumab has not significantly prolonged overall patient survival times. Glioblastoma resistance to angiogenesis inhibitors is attributed to multiple interacting mechanisms. We have thus embarked on a comprehensive effort to detecting expression signatures that are associated with response to the therapy and these signatures may allow prospective selection of patients with high likelihood of responding to therapy. Notch signaling pathway is an evolutionarily conserved pathway that plays an important role in multiple cellular and developmental processes including cell fate decision, differentiation, proliferation, survival, angiogenesis and migration. Analysis of The Cancer Genome Atlas expression dataset identified a group (43.9%) of tumors with proneural signature showing high Notch pathway activation. In this study, we compared CD133, Notch, and VEGF expressions in histological sections of primary and recurrent glioblastomas after radiotherapy and chemotherapy. Tumor samples were collected from 27 patients at the time of tumor recurrence. We used immunohistochemical techniques to compare expression of CD133, Notch-1 and VEGF. Expressions of CD133-, Notch-1-, and VEGF-positive glioma cells were higher in recurrent glioblastoma after radiotherapy and chemotherapy. To determine the clinical importance of Notch-1 expression in glioblastoma, we analyzed 15 patients who had received bevacizumab therapy followed by a second surgery at recurrence. OS was significantly longer in cases with Notch-1 negativity (8.8 months) than in those with Notch-1 positivity (6.8 months). Electron microscopic observation of two autopsy cases revealed the effects of blood vessel normalization in Notch-1 positive glioblastoma. Electron microscopic images confirmed the presence of pericytes surrounding the vascular endothelium. Autopsied tumors exhibited marked proliferation of Notch-1 and VEGF positive cells around vessels. In tumor angiogenesis, vascular endothelial growth factor and Notch signaling induce sprouting angiogenesis and recruitment of vascular endothelial cells such as tip cells, stalk cells, and phalanx cells. Fully mature phalanx cells are in close contact with pericytes. These findings indicate that bevacizumab treatment promotes vascular normalization by recruiting mature pericytes and associated with resistance to bevacizumab therapy in glioblastoma with high Notch pathway activation. Citation Format: Norihiko Saito, Kazuya Aoki, Nozomi Hirai, Satoshi Fujita, Junya Iwama, Masashi Ikota, Haruo Nakayama, Morito Hayashi, Keisuke Ito, Takatoshi Sakurai, Satoshi Iwabuchi. Notch pathway activation predicts resistance to bevacizumab therapy in glioblastoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 774. doi:10.1158/1538-7445.AM2017-774
Case Reports in Medicine | 2012
Arata Tomiyama; Hitoshi Kimura; Haruo Nakayama; Hideaki Izukura; Junichi Harashina; Keisuke Ito; Kenichiro Sato; Morito Hayashi; Norihiko Saito; Takatoshi Sakurai; Yoko Hirata; Kazuya Aoki; Satoshi Iwabuchi
A 54-year-old woman presented to our hospital with progressive motor weakness of the right arm. She had a medical history of systemic lupus erythematosus (SLE) and hypothyroidism. Magnetic resonance imaging indicated a watershed infarction of the left hemisphere. Cervical echogram indicated severe stenosis of the internal carotid artery (ICA) without wall thickening. Cerebral angiography indicated left ICA occlusion, development of unilateral moyamoya vessels, and leptomeningeal anastomosis. Encephaloduroarteriosynangiosis (EDAS) was performed after cerebral 99 mTechnetium-ethyl-cysteinate-dimer single-photon emission computed tomography indicated a decreased cerebral blood flow, diminished cerebrovascular perfusion reserve. Motor weakness finally disappeared 6 months after surgery. Moyamoya syndrome is a rare complication of both SLE and hypothyroidism, and the surgical indication remains controversial. By evaluating the decreased cerebral perfusion reserve capacity and the existence of leptomeningeal anastomosis, EDAS could be an efficient method for the treatment of moyamoya syndrome associated with SLE and hypothyroidism.
Archive | 2008
Satoshi Iwabuchi; Tetsuya Yokouchi; Hitoshi Terada; Morito Hayashi; Hitoshi Kimura; Arata Tomiyama; Y. Hirata; Norihiko Saito; Junichi Harashina; Haruo Nakayama; Kenichiro Sato; K. Hamazaki; Kazuya Aoki; Hirotsugu Samejima; Morikazu Ueda
Background We evaluated regional cerebral blood flow (rCBF) during vasospasm after subarachnoid haemorrhage (SAH) using automated voxel-based analysis of brain perfusion single-photon emission computed tomography (SPECT).
Neurologia Medico-chirurgica | 2006
Satoshi Iwabuchi; Tetsuya Yokouchi; Morito Hayashi; Hideo Uehara; Morikazu Ueda; Hirotsugu Samejima
Neurologia Medico-chirurgica | 2010
Norihiko Saito; Kazuya Aoki; Takatoshi Sakurai; Keisuke Ito; Morito Hayashi; Yoko Hirata; Kenichiro Sato; Junichi Harashina; Masaki Akahata; Satoshi Iwabuchi